Primary Site >> Pancreatic Cancer
Gene >> DLL1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. PMID: 16525728 |
Ref: Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer. PMID: 18509182 |
Ref: Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer. PMID: 19858399 |
Ref: A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma. PMID: 21750117 |
Ref: Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. PMID: 26673007 Ref: Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis. PMID: 27137215 |
Ref: Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma. PMID: 29896227 |